GW Pharmaceuticals Plc (GWPH)

147.35
5.51 3.60
NASDAQ : Health Technology
Prev Close 152.86
Open 152.51
Day Low/High 146.33 / 152.94
52 Wk Low/High 90.14 / 196.00
Volume 624.52K
Avg Volume 375.70K
Exchange NASDAQ
Shares Outstanding 30.72M
Market Cap 4.63B
EPS -9.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

GW Pharma Surges on Marijuana-Based Epilepsy Drug Sales, Analyst Upgrades

GW Pharma Surges on Marijuana-Based Epilepsy Drug Sales, Analyst Upgrades

Shares of GW Pharmaceuticals surge following soaring sales of its marijuana-derived epilepsy drug that prompts two analysts to raise their stock-price targets.

Cannabis Company Sundial Growers Wilts in Public Debut

Cannabis Company Sundial Growers Wilts in Public Debut

The shares slumped amid concern about another Canadian cannabis company's regulatory issues.

Zynerba Pharma Looks Like Bad Medicine for Investors

Zynerba Pharma Looks Like Bad Medicine for Investors

The charts make ZYNE look bearish and not particularly attractive, so avoid.

Big Victory for the Bulls: Cramer's 'Mad Money' Recap (Monday 7/22/19)

Big Victory for the Bulls: Cramer's 'Mad Money' Recap (Monday 7/22/19)

Jim Cramer says that in the heart of earnings season, Wall Street analysts can make important calls that let bulls push stocks higher.

Berkshire Hathaway, Seattle Genetics, Zynerba: 'Mad Money' Lightning Round

Berkshire Hathaway, Seattle Genetics, Zynerba: 'Mad Money' Lightning Round

Jim Cramer takes a look at Berkshire Hathaway, Seattle Genetics, Zynerba Pharmaceuticals, Range Resources, Guardant Health, Danaher and more.

WATCH for Scale: Cramer's 'Mad Money' Recap (Thursday 7/11/19)

WATCH for Scale: Cramer's 'Mad Money' Recap (Thursday 7/11/19)

Jim Cramer highlights companies that can grow so big they make their own destinies: Walmart, Amazon, Target, Costco and Home Depot.

Don't You Dare Say 'Bubble': Cramer's 'Mad Money' Recap (Wednesday 7/10/19)

Don't You Dare Say 'Bubble': Cramer's 'Mad Money' Recap (Wednesday 7/10/19)

Jim Cramer says save the bubble-talk for the bathtub. The money investors can make in the market is real, and due to ingenuity, competitiveness and economic growth.

Planet Fitness, Allergan, Amarin: 'Mad Money' Lightning Round

Planet Fitness, Allergan, Amarin: 'Mad Money' Lightning Round

Jim Cramer weighs in on Planet Fitness, Allergan, Amarin, MPLX, Zynerba Pharmaceuticals, Schnieder National, United Parcel Service and more.

What's the Difference Between Indica vs. Sativa?

What's the Difference Between Indica vs. Sativa?

Indica and sativa are commonly-known distinctions among cannabis enthusiasts. But is there actually a distinct difference between the two? What roles do cannabinoids and terpenes play?

5 Cannabis ETFs to Fire Up Your Portfolio

5 Cannabis ETFs to Fire Up Your Portfolio

Two of them are brand new.

Ben & Jerry's Wants to Get in on CBD Craze

Ben & Jerry's Wants to Get in on CBD Craze

The company's announcement comes ahead of an FDA's public hearing on the legalization of CBD-infused foods and beverages on Friday.

In the Crosshairs of the Trade War: Cramer's 'Mad Money' Recap (Tuesday 5/21/19)

In the Crosshairs of the Trade War: Cramer's 'Mad Money' Recap (Tuesday 5/21/19)

Jim Cramer reviews stocks poised to profit, and those at risk -- until we get some sign of a truce in the trade war.

Regeneron Stock Could Fall 13% to 52-Week Lows

Regeneron Stock Could Fall 13% to 52-Week Lows

Regeneron stock is under pressure after missing on earnings and revenue expectations. Are new lows on tap?

Get Out Your Shopping List: Cramer's 'Mad Money' Recap (Monday 5/6/19)

Get Out Your Shopping List: Cramer's 'Mad Money' Recap (Monday 5/6/19)

Jim Cramer's take on tariff troubles? Break out your stock shopping list and buy domestic companies that are doing well.

Take-Two Interactive, Lennox International: 'Mad Money' Lightning Round

Take-Two Interactive, Lennox International: 'Mad Money' Lightning Round

Jim Cramer weighs in on Take-Two Interactive, Lennox International, Nabors Industries, CH Robinson Worldwide, The Blackstone Group, FedEx and more.

You Don't Have to Swing for the Fences With Every Investment in Small Caps

You Don't Have to Swing for the Fences With Every Investment in Small Caps

The way I do that is by using buy-write option strategies.

9 Speculative Plays for Investors Wanting Cannabis Exposure

9 Speculative Plays for Investors Wanting Cannabis Exposure

Five top marijuana stocks and four CBD plays in this speculative space.

2 Hemp Stocks for Investors Looking for Something Different

2 Hemp Stocks for Investors Looking for Something Different

You may want to check out GW Pharmaceuticals and Elixinol Global Limited.

Melius Research Launches Cannabis Industry Coverage

Melius Research Launches Cannabis Industry Coverage

In its first report on cannabis companies, Melius says prices are high.

The Ones That Got Away: Cramer's 'Mad Money' Recap (Thursday 2/28/19)

The Ones That Got Away: Cramer's 'Mad Money' Recap (Thursday 2/28/19)

Jim Cramer lists the great stocks and the obvious winners he wishes he had talked about more.

GW Pharmaceuticals Is Ready to Rally More: How to Trade This Cannabis Stock

GW Pharmaceuticals Is Ready to Rally More: How to Trade This Cannabis Stock

My trading strategy for GWPH whether you are currently long or want to be.

Jim Cramer: My Best Stock Picks for Cannabis and China

Jim Cramer: My Best Stock Picks for Cannabis and China

And why I won't recommend any other stocks in these markets, right now.

What's Keeping You Up?: Cramer's 'Mad Money' Recap (Wednesday 2/27/19)

What's Keeping You Up?: Cramer's 'Mad Money' Recap (Wednesday 2/27/19)

Jim Cramer says if you focus on what's going right, you'll sleep better and do a lot better with your money, too.

Chart of the Week: GW Pharmaceuticals

GWPH is ready to float higher after some sideways consolidation.

Power of Positives: Cramer's 'Mad Money' Recap (Thursday 1/17/19)

Power of Positives: Cramer's 'Mad Money' Recap (Thursday 1/17/19)

Jim Cramer talks about how this market is taking its cues from the positives, and shrugging off the negatives.

Brinks, Medtronic, Fiat Chrysler: 'Mad Money' Lightning Round

Brinks, Medtronic, Fiat Chrysler: 'Mad Money' Lightning Round

Jim Cramer weighs in on Brinks, Sangamo Biosciences, Medtronic, Fiat Chrysler, GW Pharmaceuticals, EPR Properties.

Why Canada Rules as a Haven for Listing Cannabis Companies

Why Canada Rules as a Haven for Listing Cannabis Companies

The main reason most cannabis-related concerns head north to list their shares is banking.

Farm Bill's Hemp Legalization Is Poised to Boost These 2 Stocks

Farm Bill's Hemp Legalization Is Poised to Boost These 2 Stocks

Despite the current stock market, investors are still looking for ways to play the new legalization of hemp.